Physician profile
Todd Michener
NPI 1942389168
$6,845.56
in general payments reported to CMS, 2019-2025
20 companies · $238 in 2025
The $238 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,134 · 2020: $2,546 · 2021: $208 · 2022: $106 · 2023: $1,183 · 2024: $431 · 2025: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,043 · Travel and Lodging: $809.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,042.88 |
| Travel and Lodging | $808.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,654.38 | 2019-2024 | Arthrex |
| Liberty Surgical INC. | $1,980.89 | 2019-2020 | |
| Eclipse Technology Solutions INC. | $704.28 | 2023 | |
| Zimmer Biomet Holdings, INC. | $382.84 | 2021-2025 | Gel-One Cross-Linked Hyaluronate |
| Depuy Synthes Sales INC. | $325.82 | 2019-2025 | Monovisc, Orthovisc, Inhance |
| Stryker Corporation | $207.52 | 2023-2025 | Axsos, Asnis, Omega |
| Smith+Nephew, INC. | $153.26 | 2019-2024 | Evos, Bone Anchors With Arthroscopic Delivery System, Coblation |
| Horizon Therapeutics Plc | $111.99 | 2019 | |
| Ferring Pharmaceuticals INC. | $58.79 | 2022-2025 | Euflexxa |
| Exactech, INC. | $50.00 | 2019 | |
| Arteriocyte Medical Systems, INC. | $34.83 | 2019 | |
| Pacira Therapeutics, INC. | $32.98 | 2020-2021 | |
| Bioventus LLC | $30.68 | 2021 | |
| Carlsmed, INC. | $30.51 | 2023 | Aprevo |
| Ipsen Biopharmaceuticals, INC | $23.27 | 2024 | Dysport |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $17.77 | 2025 | |
| Fx Shoulder Solutions, INC | $17.58 | 2021 | |
| Appliedvr INC | $16.40 | 2025 | Relievrx |
| Orthogenrx INC. | $11.77 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$149,904.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Michener listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.